Cogent Biosciences (COGT) Receivables: 2017-2019
Historic Receivables for Cogent Biosciences (COGT) over the last 3 years, with Dec 2019 value amounting to $2.0 million.
- Cogent Biosciences' Receivables rose 19.90% to $2.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $6.4 million, marking a year-over-year increase of 8.86%. This contributed to the annual value of $2.0 million for FY2019, which is 19.90% up from last year.
- As of FY2019, Cogent Biosciences' Receivables stood at $2.0 million, which was up 19.90% from $1.7 million recorded in FY2018.
- In the past 5 years, Cogent Biosciences' Receivables registered a high of $2.0 million during FY2019, and its lowest value of $830,000 during FY2017.
- Its 3-year average for Receivables is $1.5 million, with a median of $1.7 million in 2018.
- Data for Cogent Biosciences' Receivables shows a peak YoY soared of 100.96% (in 2018) over the last 5 years.
- Over the past 3 years, Cogent Biosciences' Receivables (Yearly) stood at $830,000 in 2017, then spiked by 100.96% to $1.7 million in 2018, then grew by 19.90% to $2.0 million in 2019.